Bonelli Raphael M, Niederwieser Gerald, Diez Josef, Gruber Andreas, Költringer Peter
Department of Neurology and Psychiatry, Hospital BHB Eggenberg, Graz, Austria.
Clin Neuropharmacol. 2002 Jan-Feb;25(1):58-60. doi: 10.1097/00002826-200201000-00011.
Levodopa is recommended as a therapeutic approach for patients with the hypokinetic-rigid, Westphal variant of Huntington's disease, but no guidelines are available for the case of nonrespondence to levodopa. In this study, however, we report a 34-year-old woman with this rare variant who showed a clear-cut improvement in motor function and depressive symptoms after treatment with pramipexole, a new dopamine agonist.
左旋多巴被推荐作为患有运动不能-强直型韦斯特法尔变异型亨廷顿舞蹈病患者的一种治疗方法,但对于左旋多巴无反应的情况尚无指导方针。然而,在本研究中,我们报告了一名患有这种罕见变异型疾病的34岁女性,在用新型多巴胺激动剂普拉克索治疗后,其运动功能和抑郁症状有明显改善。